Several European countries have temporarily halted the administration of the Oxford–AstraZeneca COVID-19 vaccine, ChAdOx1
, after reports of thrombotic events occurring in individuals that had previously received the vaccine. In this video interview, we speak with Dr Andrew Preston, reader in Microbial Pathogenesis at the University of Bath, to learn more about the situation and its potential implications for global vaccination strategies. Visit the Technology Networks
COVID-19 vaccine hub page
to keep up to date with the latest vaccine news.